Evaxion A/S - EVAX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$4.941M
QoQ value delta ($000)
+$17K (+0.35%)
Implied price effect (QoQ)
+0.15%
Shares
Total shares
1,594,609
QoQ shares delta
+3,038 (+0.19%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (EVAX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 4 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Merck & Co., Inc. 3,763 1,214,126 0.71%
Ikarian Capital, LLC 231 74,698 0.02%
Rathbones Group PLC 141 45,723 0.0%
CITADEL ADVISORS LLC 113 36,584 0.0%
RENAISSANCE TECHNOLOGIES LLC 104 33,800 0.0%
Annis Gardner Whiting Capital Advisors, LLC 93 30,000 0.01%
J. Safra Sarasin Holding AG 75 22,896 0.0%
RHUMBLINE ADVISERS 67 21,849 0.0%
JANE STREET GROUP, LLC 63 20,581 0.0%
SmartHarvest Portfolios, LLC 58 17,962 0.02%
BOOTHBAY FUND MANAGEMENT, LLC 57 18,426 0.0%
Stonepine Capital Management, LLC 54 17,562 0.03%
XTX Topco Ltd 39 12,899 0.0%
WESBANCO BANK INC 31 10,000 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 24 8,000 0.0%
UBS Group AG 19 6,275 0.0%
GAMMA Investing LLC 9 2,948 0.0%
BESSEMER GROUP INC 0 18 0.0%
SBI Securities Co., Ltd. 0 262 0.0%